Evoke Pharma Inc. (EVOK) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Evoke Pharma Inc.

    NASDAQ: EVOK · Real-Time Price · USD
    4.90
    -0.11 (-2.20%)
    At close: Sep 26, 2025, 3:59 PM
    4.73
    -3.47%
    After-hours: Sep 26, 2025, 05:21 PM EDT

    Evoke Pharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 13.6M 4.74M 9.84M 9.14M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 126.92K 241.64K -129.07K -12.43K
    Receivables
    		 2.42M 673.07K 624.83K 295.19K
    Inventory
    		 445.08K 481.84K 289.38K 185.53K
    Other Current Assets
    		 43.9K 47.53K 11.55K 11.55K
    Total Current Assets
    		 17.24M 6.83M 11.72M 10.56M
    Property-Plant & Equipment
    		 154.18K n/a 129.07K 12.43K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 281.11K 241.64K 129.07K 12.43K
    Total Assets
    		 17.52M 7.07M 11.85M 10.57M
    Account Payables
    		 2.34M 1.71M 868.31K 874.03K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 5M 5M 129.07K 12.43K
    Other Current Liabilities
    		 2.11M 1.32M 528.08K 506.89K
    Total Current Liabilities
    		 10.38M 9.65M 1.65M 1.41M
    Long-Term Debt
    		 n/a 5M 5M 5M
    Other Long-Term Liabilities
    		 n/a 1.61M 1.11M 612.29K
    Total Long-Term Liabilities
    		 100.96K 6.61M 6.11M 5.61M
    Total Liabilities
    		 10.48M 9.65M 7.77M 7.02M
    Total Debt
    		 5.16M 5M 5.13M 5.01M
    Book Value
    		 7.04M -2.58M 4.08M 3.56M
    Book Value Per Share
    		 3.69 -9.26 15.59 15.91
    Common Stock
    		 149.00 334.00 334.00 3.27K
    Retained Earnings
    		 -128.79M -123.44M -115.65M -107.42M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 7.04M -2.58M 4.08M 3.56M
    Total Investments
    		 13,596.6B n/a n/a n/a

    Add to Watchlist